Prevalence and mechanism of fluoroquinolone resistance in clinical isolates of Proteus mirabilis in Japan
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 32 references indexed in Scilit:
- Fourteen years in resistanceInternational Journal of Antimicrobial Agents, 2012
- Genetic Features of bla NDM-1 -Positive EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2011
- Epidemiology of Ciprofloxacin Resistance and Its Relationship to Extended-Spectrum β-Lactamase Production inProteus mirabilisBacteremiaThe Korean Journal of Internal Medicine, 2011
- Urinary tract infection caused by fluoroquinolone- and cephem-resistant EnterobacteriaceaeInternational Journal of Antimicrobial Agents, 2006
- Clinical Epidemiology of Ciprofloxacin Resistance and Its Relationship to Broad-Spectrum Cephalosporin Resistance in Bloodstream Infections Caused by Enterobacter SpeciesInfection Control & Hospital Epidemiology, 2005
- Trends in Antimicrobial Susceptibilities among Enterobacteriaceae Isolated from Hospitalized Patients in the United States from 1998 to 2001Antimicrobial Agents and Chemotherapy, 2003
- DNA Gyrase and Topoisomerase IV Mutations Associated with Fluoroquinolone Resistance in Proteus mirabilisAntimicrobial Agents and Chemotherapy, 2002
- Type II Topoisomerase Mutations in Fluoroquinolone-Resistant Clinical Strains of Pseudomonas aeruginosa Isolated in 1998 and 1999: Role of Target Enzyme in Mechanism of Fluoroquinolone ResistanceAntimicrobial Agents and Chemotherapy, 2001
- Emerging Mechanisms of Fluoroquinolone ResistanceEmerging Infectious Diseases, 2001
- Epidemiology of Ciprofloxacin Resistance and Its Relationship to Extended-Spectrum -Lactamase Production in Klebsiella pneumoniae Isolates Causing BacteremiaClinical Infectious Diseases, 2000